It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss). Following instructions provided in the packaging, she mixed the powder and water and put it in the fridge, taking out one-fourth to one-half a ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose pounds with fewer side effects than current anti-obesity medications on the market.

When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated the market for the new GLP-1 weight-loss medicines. When Novo’s competitor Eli Lilly reported its earnings last week,

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,

These drugs have also been in and out of shortage, making it tough to get your hands on Ozempic and similar medications—if you can afford it. Semaglutide medications like Ozempic and Wegovy are also reportedly getting closer to moving off the shortages list,